Liver scan may predict deadly failure after big operations

NCT ID NCT02753517

Completed Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a special liver scan (hepatobiliary scintigraphy) can predict liver failure in 326 patients undergoing major liver surgery. The scan measures how well the remaining liver works, which may be more useful than just measuring its size. If accurate, it could help doctors identify high-risk patients and improve surgical planning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Hepatobiliary scintigraphy (imaging scan)
What this could lead to: If successful, this scan could help surgeons better predict which patients are at risk of liver failure after major liver surgery, potentially reducing complications.
What could go wrong: This is an observational study, not a treatment trial. The scan's accuracy may be limited, and results may not apply to all patients or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATIC INSUFFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hepatic Insufficiency liver and intrahepatic bile duct neoplasm liver failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATIC INSUFFICIENCY

Contacts and locations

Locations

AP-HPHôpital Beaujon,

Paris, France
CHRU, Hôpital Claude Huriez

Lille, France
CHU

Bordeaux, France
CHU

Grenoble, France
CHU

Marseille, France
CHU

Rouen, France
CHU

Toulouse, France
Centre Leon Berard - Lyon 08

Lyon, 69008, France
Chru Nancy - Hopitaux de Brabois

Nancy, France
Hopital Croix-Rousse - Hcl - Lyon 04

Lyon, 69008, France
Hopital Estaing - Chu63 - Clermont Ferrand

Clermont-Ferrand, France
Hôpital Nord, CHU

Amiens, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.